Piramal Pharma Releases Q3FY26 Earnings Call Transcript Following Results Discussion
Piramal Pharma has released the transcript of its Q3FY26 earnings conference call held on January 29, 2026, making it available on the company website as part of regulatory compliance under SEBI LODR regulations.

*this image is generated using AI for illustrative purposes only.
Piramal Pharma has announced the availability of its earnings call transcript for the quarter and nine months ended December 31, 2025, following the conference call held on January 29, 2026. The pharmaceutical company has made the transcript publicly accessible as part of its regulatory compliance obligations.
Regulatory Compliance Filing
The company filed the announcement with stock exchanges on January 30, 2026, in continuation of its earlier communication dated January 16, 2026. The filing was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Filing Details: | Information |
|---|---|
| Conference Call Date: | January 29, 2026 |
| Results Period: | Quarter and nine months ended December 31, 2025 |
| Filing Date: | January 30, 2026 |
| Regulation: | SEBI LODR Regulation 30(6) |
Document Availability
The transcript of the conference call discussing the unaudited financial results (standalone and consolidated) has been made available on the company's official website at piramalpharma.com under the financial reports section. This follows the company's commitment to transparency and regulatory compliance in investor communications.
Exchange Communication
The announcement was formally communicated to both BSE Limited (scrip code: 543635) and National Stock Exchange of India Limited (symbol: PPLPHARMA). The filing was digitally signed by Company Secretary Tanya Sanish on January 30, 2026.
The availability of the earnings call transcript provides stakeholders with detailed insights into the company's Q3FY26 performance discussions and management commentary on the financial results for the reporting period.
Historical Stock Returns for Piramal Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.99% | -2.19% | +6.37% | -16.44% | -22.94% | -13.20% |


































